This inventor holds 1 USPTO granted patent. Top assignee: Academy of Military Medical Sciences. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Maomin Lv: Innovator in Plasma Protein Separation
Introduction
Maomin Lv is a distinguished inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the area of plasma protein separation and purification. His innovative methods have the potential to enhance clinical applications and improve the utilization of plasma resources.
Latest Patents
Maomin Lv holds a patent for a method titled "Method for separating and purifying α2-macroglobulin from Cohn Fraction IV precipitation." This invention outlines a process that involves treating Cohn Fraction IV precipitation through ammonium sulfate precipitation, zinc ion affinity chromatography, gel filtration, and ultrafiltration and concentration. The result is the successful extraction of purified α2-macroglobulin plasma protein, which has significant clinical application value. This method transforms what was once considered a discarded material into a valuable resource, showcasing the comprehensive utilization of plasma.
Career Highlights
Maomin Lv is affiliated with the Academy of Military Medical Sciences, where he continues to advance research in the field of medical science. His work not only contributes to scientific knowledge but also has practical implications for healthcare and treatment methodologies.
Collaborations
Maomin Lv has collaborated with notable colleagues, including Yuyuan Ma and Chaoji Huangfu. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Maomin Lv's contributions to the field of plasma protein separation exemplify the impact of innovative thinking in medical science. His patented methods not only improve the efficiency of protein purification but also hold promise for future clinical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile